Probleme beim Einloggen

Drug Safety

Die Gruppe Drug Safety befasst sich mit allen Belangen der Arzneimittelsicherheit.

Marc Rilling Challenges from the CRO - create bioanalytical reports in minutes
Pharmaceutical companies are increasingly transferring their processes to CROs in order to achieve the goal of a decreasing time-to-market period.
iStudyReporter Bioanalytics will lift the automation in the bioanalytical lab to the next level – it is the industry standard for the automated creation of report documents from Watson LIMS.
Find out more in our pre-conference webinars on:
March 15, 2018 at 10 am EST
March 20, 2018 at 11 am PST
We are looking forward to welcoming you.
Parmshwar Karkale All You Need to Know About the Global Oncology drugs Market Is Here!
Oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period. Such high growth rate is majorly due to increasing awareness towards advanced therapies namely immunotherapies and increase in per capita healthcare spending.
Key companies profiled in the report are Roche diagnostics, Novartis AG, Celgene Corporation, AstraZeneca, Johnson & Johnson, Merck & Co., Eli Lilly & Co. and GlaxoSmithKline. Companies operating in the cancer drugs market focus on several strategies such as collaboration, approval and acquisition.
The report provides the quantitative analysis of the current market and estimations through 2013-2020 that assists in identifying the prevailing market opportunities to capitalize on
The report helps in understanding the strategies adopted by various companies for gaining market share in the cancer drugs market
Get the sample PDF Brochure of market study @


Infos zu den Moderatoren

Über die Gruppe "Drug Safety"

  • Gegründet: 13.11.2013
  • Mitglieder: 150
  • Sichtbarkeit: offen
  • Beiträge: 95
  • Kommentare: 1